TITAN MEDICAL INC (TMD.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:TMD - CA88830X8199 - Common Stock
0.8 CAD
-0.04 (-4.76%)
We assign a fundamental rating of 2 out of 10 to TMD. TMD was compared to 16 industry peers in the Health Care Equipment & Supplies industry. TMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TMD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- TMD had negative earnings in the past year.
- In the past year TMD has reported a negative cash flow from operations.
- In the past 5 years TMD reported 4 times negative net income.
- In the past 5 years TMD reported 4 times negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -111.81%, TMD is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
- TMD's Return On Equity of -184.94% is in line compared to the rest of the industry. TMD outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -111.81% | ||
| ROE | -184.94% | ||
| ROIC | N/A |
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- In the last couple of years the Operating Margin of TMD has grown nicely.
- The Profit Margin and Operating Margin and Gross Margin are not available for TMD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- TMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for TMD has been increased compared to 1 year ago.
- The debt/assets ratio for TMD has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -81.60, we must say that TMD is in the distress zone and has some risk of bankruptcy.
- TMD has a worse Altman-Z score (-81.60) than 81.25% of its industry peers.
- A Debt/Equity ratio of 0.22 indicates that TMD is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.22, TMD is doing good in the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -81.6 |
ROIC/WACCN/A
WACC7.75%
2.3 Liquidity
- TMD has a Current Ratio of 3.73. This indicates that TMD is financially healthy and has no problem in meeting its short term obligations.
- TMD's Current ratio of 3.73 is amongst the best of the industry. TMD outperforms 81.25% of its industry peers.
- A Quick Ratio of 3.73 indicates that TMD has no problem at all paying its short term obligations.
- TMD's Quick ratio of 3.73 is amongst the best of the industry. TMD outperforms 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 3.73 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 65.90% over the past year.
- The Revenue for TMD has decreased by -94.31% in the past year. This is quite bad
- TMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.11% yearly.
EPS 1Y (TTM)65.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.99%
Revenue 1Y (TTM)-94.31%
Revenue growth 3Y-4.11%
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TMD. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- TMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TITAN MEDICAL INC / TMD.CA FAQ
Can you provide the ChartMill fundamental rating for TITAN MEDICAL INC?
ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA.
Can you provide the valuation status for TITAN MEDICAL INC?
ChartMill assigns a valuation rating of 0 / 10 to TITAN MEDICAL INC (TMD.CA). This can be considered as Overvalued.
Can you provide the profitability details for TITAN MEDICAL INC?
TITAN MEDICAL INC (TMD.CA) has a profitability rating of 1 / 10.
How financially healthy is TITAN MEDICAL INC?
The financial health rating of TITAN MEDICAL INC (TMD.CA) is 5 / 10.